Switching CF patients from previous pancreatic enzyme replacement therapy to ZENPEP™ (pancrelipase delayed-release capsules) improves symptom control of exocrine pancreatic insufficiency (EPI)

Autor: Heubi, J.E., Straforini, C., Thieroff-Ekerdt, R.
Zdroj: In Journal of Cystic Fibrosis 2010 9 Supplement 1:S77-S77
Databáze: ScienceDirect